(MedPage Today) — Amikacin liposome inhalation suspension (ALIS) improved symptoms and infection clearance in treatment-naive Mycobacterium avium complex (MAC) lung disease, the ENCORE trial showed.
For the primary endpoint, the aminoglycoside…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
